Page last updated: 2024-08-26

fulvestrant and org 33628

fulvestrant has been researched along with org 33628 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alexi, X; Bouwman, P; Dijcks, F; Jonkers, J; Klarenbeek, S; Liu, X; van de Ven, M; van der Burg, E; Zwart, W	1

Other Studies

1 other study(ies) available for fulvestrant and org 33628

Article	Year
BRCA1-associated mammary tumorigenesis is dependent on estrogen rather than progesterone signaling. The Journal of pathology, 2018, Volume: 246, Issue:1 Topics: Animals; BRCA1 Protein; Carcinoma in Situ; Cell Proliferation; Cell Transformation, Neoplastic; Drug Implants; Estradiol; Estrenes; Estrogen Receptor alpha; Estrogen Receptor Antagonists; Estrogen Receptor beta; Estrogen Replacement Therapy; Female; Fulvestrant; Mammary Neoplasms, Experimental; Mice, 129 Strain; Mice, Transgenic; Ovariectomy; Progesterone; Receptors, Progesterone; Signal Transduction; Time Factors; Tumor Burden; Tumor Suppressor Proteins	2018

Article

Year

BRCA1-associated mammary tumorigenesis is dependent on estrogen rather than progesterone signaling.

The Journal of pathology, 2018, Volume: 246, Issue:1

Topics: Animals; BRCA1 Protein; Carcinoma in Situ; Cell Proliferation; Cell Transformation, Neoplastic; Drug Implants; Estradiol; Estrenes; Estrogen Receptor alpha; Estrogen Receptor Antagonists; Estrogen Receptor beta; Estrogen Replacement Therapy; Female; Fulvestrant; Mammary Neoplasms, Experimental; Mice, 129 Strain; Mice, Transgenic; Ovariectomy; Progesterone; Receptors, Progesterone; Signal Transduction; Time Factors; Tumor Burden; Tumor Suppressor Proteins

2018